Skip to content

Vitamin D and Type 2 Diabetes Risk in UK Adults

Association Between Vitamin D Status and Risk of Type 2 Diabetes in a Population of UK Adults: A Cross-sectional Study.

Status
Suspended
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04339530
Enrollment
300
Registered
2020-04-09
Start date
2019-07-01
Completion date
2022-07-01
Last updated
2021-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight

Keywords

Vitamin D, Type 2 diabetes, Insulin resistance, Glucose

Brief summary

This study is exploring the association between vitamin D and Type 2 diabetes risk in normal weight and overweight UK adults.

Detailed description

The aim of this study is to assess the link between vitamin D status and glucose homeostasis in a population of normal weight and overweight individuals (BMI\> 18.5 Kg/m2).

Interventions

OTHERNormal weight and overweight adults

Association between vitamin D levels and insulin resistance

Sponsors

Liverpool Hope University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Normal weight and overweight and obese adults (BMI\>= 18.5 Kg/m2) with no restriction to ethnicity, occupation or socioeconomic status. * Males and females * 18-50 years

Exclusion criteria

* Patients diagnosed with diabetes type 2, myocardial infarction or coronary heart disease. * HbA1c \> 6.4% * Pregnancy * Diagnosis of liver disease (including liver enzymes \> 3 times above normal values) * Diagnosis of renal disease (creatinine of \> 150 mmol/l) * Post-menopausal women

Design outcomes

Primary

MeasureTime frameDescription
HOMA-IR (Homeostasis modelling assessment-Insulin resistance)One venous sample collected after 8 hours of fastingA venous blood sample collected for the measurement of insulin and glucose levels.

Secondary

MeasureTime frameDescription
Fasting bood glucose levelsOne venous sample collected after 8 hours of fastingA venous blood sample collected for the measurement of glucose levels
HbA1CSample collected at one single time point with no follow-upFingerprick sample
Body fat percentageMeasurement conducted in the morning after 8 hours of fastingBody fat percentage measured through DEXA
Central and brachial Systolic and Diastolic Blood pressureMeasurement taken 3 times after a-10 minute restBlood pressure measured using a digital sphygmomanometer
Augmentation indexMeasurement taken 3 times after a-10 minute restArterial stiffness assessment test

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026